Clinical Trials Browser

OTHER × Eflornithine × Gastrointestinal × Clear all

NCT02794428 2024-10-16

Chemoprevention of Gastric Carcinogenesis

Phase 2 Completed

91 enrolled 10 charts

Gastrointestinal

Gastritis, Atrophic, Stomach Neoplasms

NCT00003076 2012-12-19

Eflornithine to Prevent Cancer in Patients With Barrett's Esophagus

Phase 2 Completed

Gastrointestinal

Esophageal Neoplasms